Emrich HM - Search Results

1

Acamprosate reduces motor cortex excitability determined by transcranial magnetic stimulation.

Wohlfarth K, Schneider U, Haacker T, Schubert M, Schulze-Bonhage A, Zedler M, Emrich HM, Dengler R, Rollnik JD. Wohlfarth K, et al. Among authors: emrich hm. Neuropsychobiology. 2000;42(4):183-6. doi: 10.1159/000026691. Neuropsychobiology. 2000. PMID: 11096333 Clinical Trial.

2

Lack of psychotomimetic or impairing effects on psychomotor performance of acamprosate.

Schneider U, Wohlfahrt K, Schulze-Bonhage A, Haacker T, Caspary A, Zedler M, Emrich HM. Schneider U, et al. Among authors: emrich hm. Pharmacopsychiatry. 1998 May;31(3):110-3. doi: 10.1055/s-2007-979309. Pharmacopsychiatry. 1998. PMID: 9657238 Clinical Trial.

3

Effects of acamprosate on memory in healthy young subjects.

Schneider U, Wohlfarth K, Schulze-Bonhage A, Haacker T, Müller-Vahl KR, Zedler M, Becker H, Dengler R, Emrich HM. Schneider U, et al. Among authors: emrich hm. J Stud Alcohol. 1999 Mar;60(2):172-5. doi: 10.15288/jsa.1999.60.172. J Stud Alcohol. 1999. PMID: 10091954 Clinical Trial.

4

High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients.

Rollnik JD, Huber TJ, Mogk H, Siggelkow S, Kropp S, Dengler R, Emrich HM, Schneider U. Rollnik JD, et al. Among authors: emrich hm. Neuroreport. 2000 Dec 18;11(18):4013-5. doi: 10.1097/00001756-200012180-00022. Neuroreport. 2000. PMID: 11192620 Clinical Trial.

5

Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics.

Rollnik JD, Borsutzky M, Huber TJ, Mogk H, Seifert J, Emrich HM, Schneider U. Rollnik JD, et al. Among authors: emrich hm. Neuropsychobiology. 2002;45(2):74-80. doi: 10.1159/000048680. Neuropsychobiology. 2002. PMID: 11893863 Clinical Trial.

6

Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man.

Passie T, Karst M, Wiese B, Emrich HM, Schneider U. Passie T, et al. Among authors: emrich hm. Neuropsychobiology. 2005;51(4):226-33. doi: 10.1159/000085724. Epub 2005 May 12. Neuropsychobiology. 2005. PMID: 15897673 Clinical Trial.

7

Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects.

Schneider U, Bevilacqua C, Jacobs R, Karst M, Dietrich DE, Becker H, Müller-Vahl KR, Seeland I, Gielsdorf D, Schedlowski M, Emrich HM. Schneider U, et al. Among authors: emrich hm. Neuropsychobiology. 1999;39(1):38-43. doi: 10.1159/000026558. Neuropsychobiology. 1999. PMID: 9892858 Clinical Trial.

8

A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: A case report.

Huber TJ, Nickel V, Tröger M, Schneider U, Husstedt H, Emrich HM. Huber TJ, et al. Among authors: emrich hm. Neuropsychobiology. 1999;40(2):75-7. doi: 10.1159/000026601. Neuropsychobiology. 1999. PMID: 10474061

9

Nabilone increases choreatic movements in Huntington's disease.

Müller-Vahl KR, Schneider U, Emrich HM. Müller-Vahl KR, et al. Among authors: emrich hm. Mov Disord. 1999 Nov;14(6):1038-40. doi: 10.1002/1531-8257(199911)14:6<1038::aid-mds1024>3.0.co;2-7. Mov Disord. 1999. PMID: 10584686 Clinical Trial. No abstract available.

10

[Diagnostic theory of normal and disordered consciousness].

Schneider U, Emrich HM. Schneider U, et al. Among authors: emrich hm. Dtsch Med Wochenschr. 2000 Aug 18;125(33):A13-4. Dtsch Med Wochenschr. 2000. PMID: 10994403 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters